Health Care · Nasdaq Stockholm · FYE 12-31 · Prices AT CLOSE 2026-07-28 (SEK) — end-of-day, never a live or intraday quote
Last SEK 56.50Day +1.62%Mkt cap $858MP/E (FY) 22.8×1Y +6.8%Off 52W high −21.6%Vol (1Y) 28.7%
Daily closing price, split-adjusted to the current basis; 2.8y shown of 1,139 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Fair value (model)SEK 47.09 |
| Implied upside−16.7% |
| Valuation confidenceMEDIUM |
| Price impliesPLAUSIBLE · 16.5% growth |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run.
| P/E (FY)22.8× |
| Sales (TTM)SEK 6.52B |
| Earnings (TTM)SEK 366.0M |
| ROE14.4% |
| Net margin5.6% |
| ROIC13.3% |
| Debt / equity1.02× |
| Total debt / EBITDA1.63× |
| EPS growth 3Y60.5% |
| Sales growth 3Y11.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (SEK). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−13.8% |
| 1Y+6.8% |
| 3Y+45.6% |
| Since incept. (ann.)+4.7% |
Total return through 2026-07-28 · series begins 2021-10-29. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)28.7% |
| Ann. volatility (3Y)33.1% |
| Sharpe (1Y)0.38 |
| Sharpe (3Y)0.57 |
| Max drawdown (1Y)−24.2% |
| Max drawdown (3Y)−30.4% |
| Beta (3Y vs SPY)0.60 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for SYNSAM.ST.
No reported quarters on file for SYNSAM.ST.
